http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102391304-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C30B29-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate | 2011-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102391304-B |
| titleOfInvention | 4-(2'-pyridine)-pyrimidine diperoxovanadate ammonium salt coordination compound and single crystal culture method and application thereof |
| abstract | The invention belongs to the field of medicinal and chemical techniques and particularly relates to a 4-(2'-pyridine)-pyrimidine diperoxovanadate ammonium salt coordination compound and a single crystal culture method and application thereof. The molecular formula of the 4-(2'-pyridine)-pyrimidine diperoxovanadate ammonium salt coordination compound is C9H15N4O7V, the molecular mass is 342.18 and the structural formula is shown as the formula 1. The 4-(2'-pyridine)-pyrimidine diperoxovanadate ammonium salt coordination compound can be used for antidiabetic researches. When the concentration of the coordination compound is at a micromolar level, the coordination compound has an inhibiting effect on protein tyrosine phosphatase (PTPase) and has a para-insulin activity. The single crystal culture method of the coordination compound is simple, the materials are easy to obtain and a new drug development means is provided for the treatment of diabetes mellitus. |
| priorityDate | 2011-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 121.